BlackLine (BL) Q2 2026 earnings review
Platform Strategy Accelerates, But AI Evaluations Stall Deal Momentum
BlackLine posted solid 9.2% revenue growth and impressive margin expansion (23.3% non-GAAP operating margin), driven by the successful migration of customers to its Studio360 platform. However, beneath the surface, the transition is creating friction. Calculated billings growth decelerated sharply to 5.9%, and Dollar-Based Net Revenue Retention (DBNRR) reversed downward to 102%. Management explicitly cited that 'deal timing was noisy' as enterprise customers conduct more rigorous evaluations of the new AI offerings. Paradoxically, the excitement surrounding the new Verity AI agents is causing buyers to pause and measure before they sign, weighing on forward-looking metrics.
🐂 Bull Case
Platform pricing ARR jumped to 17% of eligible ARR, proving that the shift from seat-based licenses to the unified Studio360 platform is resonating and fundamentally improving deal economics.
The company demonstrated excellent operational leverage, expanding non-GAAP operating margins to 23.3% with Q3 guidance forecasting further acceleration up to 25.5%.
🐻 Bear Case
DBNRR slipped to 102% after holding steady at 105% for several quarters. The strategic pivot away from the lower mid-market continues to drag on the installed base.
With billings growth dropping to 5.9%, it is clear that larger, AI-centric enterprise deals are requiring longer approval times, introducing execution risk in the second half of the year.
⚖️ Verdict: ⚪
Neutral. Management is executing flawlessly on profitability and platform migration. However, the severe deceleration in billings and DBNRR indicates that the market's digestion of AI tools is slowing down the actual cash register.
Key Themes
AI Excitement is Elongating Sales Cycles
A critical macro and operational theme emerged: the very AI tools meant to drive growth are stalling deal velocity. Management noted that 'deal timing was noisy this quarter as customers work through more rigorous, AI-driven evaluations.' When a company shifts from selling workflow software to selling Agentic AI, the buyer profile changes (often requiring CIO or 'AI Czar' approval), creating a temporary bottleneck in bookings.
Billings Growth Decelerating Sharply
Decelerating. While recognized revenue grew 9.2%, calculated billings grew only 5.9% YoY to $193.0 million. This is a sharp drop from the 11% billings growth seen exactly one year ago (25Q2) and the 9.2% seen last quarter. This forward-looking metric explicitly contradicts the narrative of 'accelerating adoption' and suggests deal slippage into the back half of the year.
Net Revenue Retention Reverses Downward
Reversing. DBNRR dropped to 102%, down from the 105% level it maintained through 26Q1 and late 2025. This metric reflects the ongoing friction of user attrition from legacy seat-based models and the intentional, strategic churn in the lower mid-market. Until this cohort is fully flushed out, retention metrics will look anemic compared to SaaS peers.
Platform Pricing Adoption is Accelerating
Accelerating. The transition to the Studio360 platform is working. Platform pricing ARR as a percentage of eligible ARR hit 17%, a significant jump from 13% in 26Q1 and 11% in 25Q4. By detaching pricing from pure seat counts, BlackLine is securing larger initial deal sizes and setting the stage for future consumption-based revenue.
Commercialization of Verity AI Agents
Product innovation is transitioning into direct monetization. 'Verity Prepare'—BlackLine's agentic reconciliations agent—reached general availability in July. Furthermore, the company announced the expansion of the Agentic Financial Operations Platform via the 'Finance Control Console'. Management confirmed that Verity usage is starting to generate direct revenue, marking the first real proof points of the AI consumption model.
Consistent Margin Expansion
Accelerating. Operating leverage continues to be a highlight. Non-GAAP operating margin expanded to 23.3% (up from 22.1% a year ago and 21.6% last quarter). General & administrative and R&D expenses are growing slower than revenue, proving that the company's internal efficiency initiatives (including their own use of AI for coding) are flowing directly to the bottom line.
Other KPIs
Decelerating slightly. RPO grew 16.8% YoY, which is a step down from the 17.9% growth seen in 26Q1 and 23.5% in 25Q4. However, it remains significantly higher than recognized revenue growth, indicating that the customers who do sign are committing to longer, larger platform contracts.
Stable and healthy. FCF grew 43% YoY from $25.4 million in 25Q2. This strong cash generation allowed the company to comfortably repurchase 1.2 million shares for $37.7 million during the quarter, while announcing a $100 million increase to the total buyback program.
Guidance
Decelerating. The midpoint of $194 million implies an 8.8% YoY growth rate (compared to $178.3M in 25Q3). This indicates a slight slowdown from the 9.2% achieved in Q2 and the 9.7% in Q1, reflecting the deal timing issues mentioned by management.
Accelerating. The midpoint of 25.0% represents a robust sequential jump from 23.3% in Q2, demonstrating that management has tight control over the cost structure heading into the back half of the year.
Stable. The company simply reiterated its prior full-year guidance range (previously $767M midpoint). By not raising the full-year guide despite beating Q2 consensus, management is baking in conservatism regarding the elongated AI sales cycles.
Key Questions
Impact of AI Evaluations on Sales Cycles
You noted that deal timing was 'noisy' due to rigorous AI-driven evaluations. Exactly how many days or weeks are being added to the typical enterprise sales cycle, and are you adapting your GTM motion to accelerate these technical approvals?
Billings Deceleration Disconnect
Calculated billings growth decelerated to 5.9% while revenue grew 9.2% and RPO grew 16.8%. Is this gap entirely driven by deal slippage, or are we seeing a change in billing terms and contract structures with the new Studio360 platform?
DBNRR Floor
With Net Revenue Retention dipping to 102%, when do you expect the headwind from the lower mid-market strategic pivot to fully wash out of the metric and allow DBNRR to re-accelerate?
Direct Monetization of Verity
Now that Verity Prepare is generally available, can you outline the specific consumption or pricing mechanics? How material of an ARR contribution do you expect from direct Agentic AI monetization in FY26 vs FY27?